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Introduction 1 
‘The prescribing of multiple medicines inappropriately, or where the intended benefit of the 2 
medicines are not realised’ is known as problematic polypharmacy [1]. Polypharmacy can 3 
decrease medication adherence and increase the incidence of adverse drug reactions (ADRs) 4 
and drug-drug interactions, resulting in falls, hospitalisations and other complications 5 
especially in the elderly [2]. Medication-related problems of polypharmacy can be prevented 6 
through patient-centred medication reviews [1]. There is some evidence that pharmacist-led 7 
polypharmacy services for older people reduce inappropriate prescribing internationally [3]. 8 
However, there is a perception that the majority of research in this area has been completed 9 
without examining patients’ viewpoints [1]. One qualitative study conducted with patients to 10 
gather views about pharmacist-run medication review clinics in general practice found wide-11 
ranging views that were themed by the authors according to patient perceptions before the 12 
reviews and then their experiences of attending [4].  13 
Patient involvement in decisions about medication use is fundamental in polypharmacy.  For 14 
example, there is conflicting evidence on patients’ willingness to accept prescriber decisions 15 
to de-prescribe [5] and doctors worry about patients’ unwillingness to stop longstanding 16 
medications [6]. Patient feedback about polypharmacy medication reviews is arguably a key 17 
indicator of the success of such services. Alongside this, the NHS in England has been 18 
working with the Royal Pharmaceutical Society (RPS) on a three-year pilot to test the role of 19 
clinical pharmacists within General Practice (GP) surgeries [7]. There is a gap in the 20 
literature in relation to outcomes associated with pharmacist-led medication reviews 21 
conducted within GP practices in England, specifically patients’ perception of such services.  22 
Aim of the study 23 
The aim of this study was to investigate patient views about a patient-centred clinical 24 
pharmacist-led polypharmacy medication review service completed within GP practices with 25 
those 75 years of age and prescribed 15 medications. 26 
Ethics approval 27 
Ethical approval was granted by the University’s Research Ethics procedures (School of 28 
Food, Chemistry and Pharmacy Ethics Review Committee) in January 2016. 29 
Methods 30 
The patient-centred pharmacist-led polypharmacy medication review service 31 
There were 819 patients (0.39% to 2.99% of patients registered with each practice) who were 32 
75 years of age and prescribed 15 medications (excluding palliative care cases and those in 33 
registered care homes) in the 34 GP practices in Windsor, Ascot & Maidenhead (in south east 34 
England); more than half (56%) were female. The highest percentage of patients taking ≥15 35 
medicines was in the 70-79 year old age band (28%). All 819 patients were invited via a letter 36 
to a pharmacist-led medication review at 17 GP practices in Windsor, Ascot & Maidenhead 37 
between April 2015 and March 2016.   38 
Reviews were completed by one of four pharmacist independent prescribers employed by 39 
Clinical Commissioning Groups (CCGs) as prescribing support clinical pharmacists. The 40 
reviews drew on the principles of patient-centred care, medicines optimisation in 41 
polypharmacy [1], and other good-practice guidelines [8] with direct access to the medical 42 
record and in discussion with the patient. Medication changes were enacted directly on 43 
electronic systems by the pharmacist independent prescribers. The main intervention element 44 
was prescription changes as well as patient education and signposting.  A record of all 45 
changes and recommendations, reasons for changes and projected annual cost savings were 46 
made contemporaneously and are described below.   47 
A total of 415 consultations (with 415 different patients) were completed (51% attendance 48 
rate) in 17 GP practices, resulting in a total of 901 medication-related changes. The changes 49 
involved stopping a medication, adding a medication, decreasing a dose, and increasing a 50 
dose. The reasons for changes were documented and categorised as relating to prescribing 51 
quality (improving clinical management or preventing harm from the medication), patient 52 
reported side-effects and formulary recommendations.  Some example and reasons for 53 
common changes made included stopping an anticholinergic to reduce the risk of adverse 54 
drug reactions; starting medication for prevention of osteoporotic fractures; adjusting the 55 
dose or time of furosemide to reduce adverse drug reactions; up titration of ACE inhibitor 56 
dose in heart failure to reduce morbidity. Pharmacists also signposted patients to other 57 
services such as a falls clinic or talking therapies. A net saving of around £37,000 per annum 58 
(£90 / patient) was predicted based on the prescribing changes, with -£46,000 as cost savings 59 
and +£9,000 as additional spends on medication.   60 
Data collection and analysis 61 
A patient feedback questionnaire was constructed and face validated with two pharmacists 62 
then posted by a CCG pharmacist to all patients who had taken part in the service within 63 
three months of attending. CCGs are clinically-led health bodies responsible for the planning 64 
and commissioning of health care services for local areas in England. There are 209 CCGs in 65 
England and this study covered three CCGs. Data from returned questionnaires were 66 
transferred to SPSS (v21) and analysed using descriptive statistics. Qualitative patient 67 
comments were analysed using thematic analysis meaning data were examined, coded, and 68 
themed for important ideas that related to the research question [9].  69 
Results 70 
Patient views 71 
Completed questionnaires were returned by 166 patients resulting in a 40% response rate. 72 
The majority (n=138; 83%) found the service helpful, 21 (13%) did not, 4 (2%) did not know 73 
and 3 (2%) did not respond. The concerns of 50 (94%) of the 53 people who indicated they 74 
had a concern about their medications before their appointment were addressed, but for 2 75 
(4%) these were not and 1 (2%) did not know. Overall 132 (80%) indicated that they 76 
understood their medicines better since the pharmacist review, 21 (13%) did not, 8 (5%) did 77 
not know and 5 (3%) did not respond. Finally, 138 (83%) people were likely or extremely 78 
likely to recommend the GP surgery to friends and family if they needed similar care or 79 
treatment; 8 (5%) were neither likely nor unlikely, 9 (5%) were unlikely or extremely 80 
unlikely and 11 (7%) were unsure. Table 1 outlines the main themes derived from analysis of 81 
qualitative responses. A small number of negative comments stated the service was not useful 82 
especially for non-English speaking patients and for those with impaired cognition.  83 
Discussion 84 
The feedback received from patients about the patient-centred pharmacist-led polypharmacy 85 
medication reviews indicated that the majority found these helpful, most understood their 86 
medicines better since the review, and almost all who had concerns about their medication 87 
beforehand felt these were addressed. Qualitatively, patients appreciated pharmacists’ 88 
personal approach, advice and explanation, listening skills and ability to address their 89 
concerns; patients expressed satisfaction with the service and some felt it increased their 90 
confidence and knowledge of their medication. 91 
The strengths of this study are that it reports on an area of activity where there is a distinct 92 
lack of published research. It reports on patient views about medication reviews completed by 93 
pharmacists working within GP practices. Patients were broadly happy with the service and 94 
seeing that the service in the main involved changes being made to patient prescriptions, the 95 
paper supports the idea that pharmacist-led prescribing decisions, including de-prescribing 96 
decisions, are acceptable to patients. This is important because patients’ willingness to accept 97 
prescribing decisions is key to the long-term success of medication reviews. 98 
The patient feedback questionnaire was validated with two pharmacists only. In addition, 99 
only 51% of those invited actually attended a review and of these only 40% returned a 100 
completed patient feedback questionnaire. Therefore there is a cohort of patients not 101 
represented by this study.  In addition, this study did not measure views in the longer term. 102 
The Department of Health in England is proposing to restructure the provision of community 103 
pharmacy services with a focus on clinical services that are better integrated with primary 104 
care [10]. Studies such as the current one add to the evidence base to support a shift towards 105 
the employment of clinical pharmacists within GP practices, at least as far as short-term 106 
patient views are concerned. Future research should examine the longer-term effects of 107 
pharmacist interventions on health outcomes such as hospital admissions.  108 
Conclusion 109 
The majority of patients who participated in a patient-centred pharmacist-led polypharmacy 110 
medication review service within GP practices in Windsor, Ascot & Maidenhead, which had 111 
resulted in numerous changes to patients’ medication, expressed positive views about the 112 
service. Further research is needed to investigate clinical outcomes associated with such 113 
reviews.  114 
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Table 1. Themes derived from patient comments about the pharmacist-led polypharmacy 164 
medication reviews 165 
Main theme and sub-themes Examples  
Process  
The pharmacist’s personal 
approach  
 “Found someone kind that cares about me.” (P133) 
Being listened to “Made me feel as if they were listening to my 
concerns about my medications.” (P115) 
“Had time to talk and didn't rush me at all.” (P112) 
The pharmacist’s advice and 
explanations 
“Thank you [pharmacists name] for your clear and 
concise explanation of my medication.” (P144) 
“The pharmacist explained everything properly and I 
felt they understood me.” (P66) 
Questions or concerns being 
answered 
“This review I found very helpful and all my 
questions were answered more than adequately.” 
(P1) 
“I thought there were perhaps some side effects from 
my medication that I currently take, so good 
discussion.” (P107) 
Outcome  
Increased confidence or 
knowledge about medication 
“More confident getting medicines right.” (P4) 
“Elderly people tend to take their meds not really 
knowing what it is for and how it works. I personally 
learnt quite a bit by seeing the pharmacist. Overall 
experience was very valuable for me.” (P30) 
General satisfaction with the 
service 
“Feels privileged to have had this appointment.” 
(P122) 
“Enlightenment. This service is tantamount to a 
‘second opinion’, very helpful and puts your mind to 
rest.” (P18) 
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